Incyte Biosciences Denmark ApS: Financial statements 2021
CVR: 35818790
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
Incyte Biosciences Denmark ApS (CVR 35818790) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK 5,287,823 and a net result of DKK 268,531 compared with DKK 150,425 the year before. That is a decrease of 2% compared with the year before. Equity in the 2021 report amounted to DKK 945,939. The solvency ratio was 27.5%. The company had 4 employees in the financial year.
- Gross Profit
- DKK 5,287,823
- Profit/Loss
- DKK 268,531
- Equity
- DKK 945,939
- Total Assets
- DKK 3,442,193
- Employees
- 4
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | 5.3M | 269K | 946K | 4 |
| 2020 | - | 5.4M | 150K | 677K | 3 |
| 2019 | - | 4.8M | 286K | 527K | 3 |
| 2018 | - | 3M | 87K | 241K | 2 |
| 2017 | - | 2M | 47K | 154K | 1 |
Official annual report
Find more companies like Incyte Biosciences Denmark ApS
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorEvents in 2021
Incyte Biosciences Denmark ApS has published its annual report for 2020. Gross profit came to DKK 5,397,378, and the net result was DKK 150,425.
About Incyte Biosciences Denmark ApS
Incyte Biosciences Denmark ApS is a Danish company of the type Anpartsselskab based in Frederiksberg C, founded in 2014. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named ARIAD PHARMACEUTICALS (DENMARK) ApS. The management consists of Ebba Cecilia Bröms. The board consists of Lee Jason Heeson (chair) and Ebba Cecilia Bröms. The company is owned by Incyte Biosciences International Sàrl. The company has 4 employees (2026). In 2025, the company reported a gross profit of DKK 6,696,586 and a net result of DKK 361,151 compared with DKK 368,873 the year before. Equity in the 2025 report amounted to DKK 2,328,496.
